Article
Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies
medRxiv · 2020 · James S. Terry, author Loran BR Anderson, author Michael S. Scherman, author Carley E. McAlister, author Rushika Perera, author Tony Schountz, author Brian J. Geiss, author
Key facts
| Title | Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies |
|---|---|
| First author | James S. Terry, author Loran BR Anderson, author Michael S. Scherman, author Carley E. McAlister, author Rushika Perera, author Tony Schountz, author Brian J. Geiss, author |
| Journal | medRxiv |
| Published | Sep 5, 2020 |
| DOI | 10.1101/2020.09.03.280370 |
| Devices mentioned | 073556, K800781, K802418 |
| Product codes mentioned | KIS |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1